John Carl Hoefs
Affiliation: University of California
- Noninvasive evaluation of liver disease severityJohn Carl Hoefs
Department of Medicine, University of California Irvine University of California Medical Center, 101 City Drive, South Orange, CA 92668, USA
Clin Liver Dis 10:535-62, viii-ix. 2006..This article reviews the methods for evaluating the severity of liver disease noninvasively by estimating function or structure...
- Factors affecting the quantitative liver-spleen scan in normal individualsJohn C Hoefs
Division of Gastroenterology Liver Disease Program, Department of Medicine, University of California, Irvine UCI Medical Center, Orange, California 92868, USA
Dig Dis Sci 50:283-9. 2005..3) Fasting significantly decreased the [L/(L + S)]t, LSI, and PHM. (4) A postprandial scan may be preferable since the normal values for [L/(L + S)]t, LSI, and PHM are greater, with a narrower range, than fasting values...
- Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C TrialJohn C Hoefs
Division of Gastroenterology, University of California Irvine, Irvine, California, USA
Gastroenterology 141:900-908.e1-2. 2011....
- Precore mutant hepatitis B reactivation after treatment with CHOP-rituximabJason A Zell
Division of Hematology Oncology, Department of Medicine, College of Medicine, University of California Irvine, Irvine, CA, USA
Anticancer Drugs 16:83-5. 2005..Hepatitis B reactivation in patients receiving rituxmab-based chemotherapy is reviewed and the role of precore mutant virus strains resulting in fatal complications is discussed...
- Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis CJohn Carl Hoefs
Division of Gastroenterology and Hepatology, H H Chao Comprehensive Digestive Disease Center, UCI Medical Center, 101 The City Drive South, Building 53, Room 113, Orange, CA 92868, USA
Dig Dis Sci 57:243-9. 2012..Patients who relapse have a poor response to re-treatment. We report a group of relapse patients with SVR to low-dose re-treatment after 6 months...
- Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis CHerbert L Bonkovsky
Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut, USA
Gastroenterology 131:1440-51. 2006....